HINDUSTAN BIO SCIENCES LTD. has reported Standalone financial results for the period ended June 30, 2022.
Financial Results (Q1 FY2023) - QoQ Comparison
The company has reported total income of Rs. 0.2714 crores during the period ended June 30, 2022 as compared to Rs. 0.0027 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs. -0.0251 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. -0.3852 crores for the period ended March 31, 2022.
The company has reported EPS of Rs. -0.02 for the period ended June 30, 2022 as compared to Rs. -0.38 for the period ended March 31, 2022.
Total Income | ₹ 0.2714 crs | ₹0.0027 crs | 9,951.85% |
Net Profit | ₹-0.0251 crs | ₹-0.3852 crs | 93.48% |
EPS | ₹-0.02 | ₹-0.38 | 94.74% |
Financial Results (Q1 FY2023) - YoY Comparison The company has reported total income of Rs. 0.2714 crores during the period ended June 30, 2022 as compared to Rs.0.1942 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs.-0.0251 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.-0.0754 crores for the period ended June 30, 2021.
The company has reported EPS of Rs.-0.02 for the period ended June 30, 2022 as compared to Rs.-0.07 for the period ended June 30, 2021.
Total Income | ₹ 0.2714 crs | ₹0.1942 crs | 39.75% |
Net Profit | ₹-0.0251 crs | ₹-0.0754 crs | 66.71% |
EPS | ₹-0.02 | ₹-0.07 | 71.43% |
Shares of HINDUSTAN BIO SCIENCES LTD. was last trading in BSE at Rs. 3.84 as compared to the previous close of Rs. 3.96. The total number of shares traded during the day was 8868 in over 23 trades.
The stock hit an intraday high of Rs. 3.88 and intraday low of 3.84. The net turnover during the day was Rs. 34282.00.
Source : Equity Bulls
Keywords
HindustanBioSciences
Q1FY23
ResultUpdate